Ftse Mib
34.478,84
0,05%
DAX
18.691,32
0,05%
S&P 500
5.322,64
0,29%
NASDAQ
16.935,48
0,80%
Bitcoin
68.089,48
-1,47%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Praxis Precision Medicines Inc (PRAX) Praxis Precision Medicines Inc (PRAX) Notizie

PRAX

Praxis Precision Medicines (PRAX)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:PRAX
DataOraFonteTitoloSimboloCompagnia
20/05/202414:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PRAXPraxis Precision Medicines Inc
13/05/202414:21Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PRAXPraxis Precision Medicines Inc
13/05/202414:18Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PRAXPraxis Precision Medicines Inc
12/04/202414:00GlobeNewswire Inc.Praxis Precision Medicines to Present on Ulixacaltamide at the American Academy of Neurology 2024 Annual MeetingNASDAQ:PRAXPraxis Precision Medicines Inc
05/03/202415:08Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:PRAXPraxis Precision Medicines Inc
05/03/202413:33Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:PRAXPraxis Precision Medicines Inc
05/03/202413:12Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:PRAXPraxis Precision Medicines Inc
15/02/202402:45Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:PRAXPraxis Precision Medicines Inc
12/01/202423:20Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:PRAXPraxis Precision Medicines Inc
10/01/202422:19GlobeNewswire Inc.Praxis Precision Medicines, Inc. Announces Proposed Public OfferingNASDAQ:PRAXPraxis Precision Medicines Inc
28/11/202313:00GlobeNewswire Inc.Praxis Precision Medicines to Showcase Largest Pipeline of Precision Epilepsy Programs and Breadth of Commitment to Epilepsy Treatments at Upcoming MeetingsNASDAQ:PRAXPraxis Precision Medicines Inc
21/11/202322:00GlobeNewswire Inc.Praxis Precision Medicines to Present at the Piper Sandler 35th Annual Healthcare ConferenceNASDAQ:PRAXPraxis Precision Medicines Inc
16/11/202314:00GlobeNewswire Inc.Praxis Precision Medicines Receives PRIME Designation from the EMA for elsunersen (PRAX-222) for Treatment of SCN2A Gain of Function Developmental EpilepsiesNASDAQ:PRAXPraxis Precision Medicines Inc
07/11/202313:00GlobeNewswire Inc.Praxis Precision Medicines Provides Corporate Update and Reports Third Quarter 2023 Financial ResultsNASDAQ:PRAXPraxis Precision Medicines Inc
02/11/202313:00GlobeNewswire Inc.Praxis Precision Medicines to Present at Truist Securities BioPharma SymposiumNASDAQ:PRAXPraxis Precision Medicines Inc
16/10/202313:09Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:PRAXPraxis Precision Medicines Inc
04/10/202313:56Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:PRAXPraxis Precision Medicines Inc
02/10/202319:17GlobeNewswire Inc.Praxis Precision Medicines Provides Portfolio Update at 2023 R&D DayNASDAQ:PRAXPraxis Precision Medicines Inc
27/09/202322:15GlobeNewswire Inc.Praxis Precision Medicines To Host Hybrid R&D Day on Monday, October 2, 2023NASDAQ:PRAXPraxis Precision Medicines Inc
19/09/202316:25AllPennyStocks.comBiotech Catches Major Premarket BidNASDAQ:PRAXPraxis Precision Medicines Inc
07/09/202314:00GlobeNewswire Inc.Praxis Precision Medicines to Present at H.C. Wainwright 25th Annual Global Investment ConferenceNASDAQ:PRAXPraxis Precision Medicines Inc
31/08/202314:00GlobeNewswire Inc.Praxis Precision Medicines to Present Data from Epilepsy Portfolio at the 35th International Epilepsy CongressNASDAQ:PRAXPraxis Precision Medicines Inc
09/08/202313:00GlobeNewswire Inc.Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2023 Financial ResultsNASDAQ:PRAXPraxis Precision Medicines Inc
08/08/202313:00GlobeNewswire Inc.Praxis Precision Medicines Announces Positive Data from Randomized Withdrawal Sub-Study and Long-Term Extension of Essential1 Study for UlixacaltamideNASDAQ:PRAXPraxis Precision Medicines Inc
07/08/202313:00GlobeNewswire Inc.Praxis Precision Medicines Announces Positive Results of EEG Analysis of PRAX-628 Phase 1 StudyNASDAQ:PRAXPraxis Precision Medicines Inc
03/08/202322:12GlobeNewswire Inc.Praxis Precision Medicines to Participate at the 2023 Wedbush PacGrow Healthcare ConferenceNASDAQ:PRAXPraxis Precision Medicines Inc
30/06/202322:15Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:PRAXPraxis Precision Medicines Inc
28/06/202322:48Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:PRAXPraxis Precision Medicines Inc
28/06/202322:48Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:PRAXPraxis Precision Medicines Inc
27/06/202316:02Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PRAXPraxis Precision Medicines Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:PRAX

La tua Cronologia

EU
BNPJX
BNP Paribas Domestic bon...
BITMOT
986508
Eib Tf 0% Mz25 Eur
EU
CFHBE
Credit Agricole Financem...
BOV
VFCO34R
VF
BTHB
MANAKRW
Decentraland
USOTC
SICNF
Sokoman Minerals (QB)
USOTC
BNCOY
Banco Inter (CE)
EU
MLALV
Alveen
TSXV
HBK
Highbank Resources
NASDAQ
FLWS
1 800 Flowers Com
ASX
TNC
True North Copper
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network